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INTRODUCTION
Severe limbal epithelial cell deficiency, that occurs with
the Steven-Johnson syndrome (SJS) or thermal and chemi-
cal burns, often causes covering of the corneal surface by invad-
ing neighboring conjunctival epithelial cells with ingrowth
of fibrotic tissue, stromal scarring, and neovascularization
(1). Because of these injuries, there is significant epithelial
cell damage, and the prognosis after penetrating keratoplas-
ty is usually poor. Therefore, alternative surgical treatments
such as keratoepithelioplasty and limbal transplantation have
been developed to improve the outcome of ocular surface
reconstruction of the severely injured eye (2-5). Recently,
attention has been focused on the use of ex vivo cultivated
corneal epithelial cell transplantation; this is a new approach
to ocular surface reconstruction for severe ocular surface dis-
ease (OSD) (6-8). However, there are many problems with
this approach such as inflammation, infection, prolonged
use of immunosuppressant therapy in the allograft, neovas-
cularization, the development of epithelial opacities, and
subepithelial opacities in the cultivated oral mucosal epithe-
lial transplantation. Furthermore, extra time, equipment
and facilities for culture are necessary, and continuous man-
agement and special technology are needed during the cul-
turing process. Therefore, we attempted to overcome the
problems associated with ex vivo allogenic transplantation
by using in vivo expansion. Previously, we reported ultrastruc-
tural analysis of in vivo expanded corneal epithelium on amni-
otic membrane (AM) in damaged cornea. We found that at
least 3 months might be needed for the differentiation and
proliferation of cells prior to transplant (9).
In this study, in vivo expansion of corneal epithelium in
healthy cornea was performed; after adequate growth, the
epithelial sheet was transplanted into a severely damaged
cornea. We reported three cases with a persistent epithelial
defect (PED) with limbal stem cell deficiency were success-
fully managed with surface reconstruction.
MATERIALS AND METHODS
Patients
Three patients with intractable PED were chosen for trans-
plantation. The intractable PED was diagnosed after five
months of standard medical and surgical treatment; preser-
vative-free artificial tear, serum therapy, epidermal growth
factor (EGF) solution, therapeutic contact lens, and amniotic
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The Effect of In Vivo Grown Corneal Epithelium Transplantation on
Persistent Epithelial Defects with Limbal Stem Cell Deficiency
We report our experience with corneal epithelium, grown in vivo, transplantation in
three patients with persistent epithelial defect (PED). The three patients had ocular
surface disease unresponsive to standard treatments and were therefore chosen
for transplantation. They underwent transplantation of epithelial sheets, grown in
vivo, to the most affected eye. In vivo cultivation was carried out in the cornea of a
living related donor. After epithelialization was completed, the epithelium grown on
an amniotic membrane was harvested gently; it was then transplanted into the
patient’s eye after debridement of fibrovascular tissue. The cultivated epithelium
was completely epithelialized by 2 weeks; it was well-differentiated with well-formed
hemidesmosome. On immunohistochemical staining, p63, connexin 43, and Inte-
grin β 4 were expressed in the cells on the epithelial sheet. The PED was covered
completely and maintained for 4 weeks in all cases. However, corneal erosion
recurred after 5 weeks in two cases. This novel technique demonstrates the corneal
epithelial cells can be expanded in vivo successfully on denuded amniotic mem-
brane of a healthy cornea and harvested safely. A corneal epithelial sheet, grown in
vivo, can be transplanted to treat eye with a severe ocular surface disease, such
as total limbal deficiency.
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membrane transplantation - temporary and permanent. These
patients had nearly total limbal deficiency in both eyes due
to several diseases. A blood type-matched living related donor
underwent epithelial peeling, followed by denuded amniot-
ic membrane transplantation (AMT) in the nondominant
eye; then the corneal epithelial cells were expanded in vivo.
Informed consent for the surgical procedure was obtained
from each patient and their participating relatives. We per-
formed in vivo cultivated corneal epithelial transplatation in
three eyes in three patients with severe ocular surface disease:
the primary diagnosis was a chemical burn in two cases and
SJS in one (Table 1). The eyes received cultivated corneal epithe-
lial transplantation for the purpose of covering the corneal
surface and avoiding the complications that accompany PED.
Amniotic membrane
AM was prepared at Bioland Korea (Cheonan, Korea) with
following method. After informed consent, human AM was
obtained at the time of cesarean section delivery. Under ster-
ile conditions, the AM was washed 3 times in 1,000 mL of
normal saline containing antibiotics (80 mL of Gentamicin
sulfate), and all blood clots were removed. The AMs were
frozen in preservative solution (Dulbecco’s modified eagle’s
medium [DMEM] and glycerol mixed solution) and stored
at -70℃; they were thawed just before use. 
Preparation of the in vivo grown epithelial sheet using AM
The amnion cells were removed by gentle scrubbing with
a 20% alcohol soaked scraper. The AM was trephinized into
8 mm-diameter round excisions. First, the epithelial cell layer
of the healthy donor cornea was removed with a No.15 Bard
Parker blade, then the denuded round AM was transplanted
onto the corneal surface with the epithelial side up using a
#10-0 Nylon (Fig. 1A). A therapeutic bandage contact lens
was then applied to protect the epithelium. Postoperatively,
0.3% ofloxacin (four times per day) and artificial tears (fre-
quently) were applied topically until epithelialization was
completed. A few weeks later (2-7 weeks), the expanded
epithelium with the underlying AM of the donor cornea
was harvested with a spatula and crescent knife. This har-
vest procedure was similar to superficial lamellar keratecto-
my; however, the stromal dissection was performed at a more
superficial layer, under the AM graft. The postoperative man-
agement was the same as the in vivo cultivation.
Surgical procedure
To remove fibrovascular tissue from the patient’s ocular
surface, a superficial lamellar keratectomy was performed
with a crescent knife and diamond burr. The cultivated
corneal epithelial cell sheet on the AM was transferred onto
the corneal surface; it was then sutured with 10-0 nylon.
Before the temporary AM graft was covered, epithelial sam-
ples were obtained from the donor’s cornea at the time of
the transplantation procedure; they were then processed for
microscopic examination and immunohistochemical stain-
ing. Then another AM was applied temporally with the
epithelial side down over the cultivated epithelium; 20%
autoserum was applied every 2 hr and 0.3% ofloxacin was
used four times a day for 2 weeks after surgery. 
Microscopic examination and immunohistochemical
staining 
The peripheral rim of these transplants were partly excised
before surgery; they were then prepared for examination by
light and JOEL JEM-1200CX transmission electron micro-
scopy. The density of the adhesion complex such as the hemi-
desmosome, was evaluated as previously described (10). The
hemidesmosome density was calculated based on the aver-
Case
Sex/
age
Diagnosis Problem Size of PED
Limbal 
deficiency
Donor
sex/age
Cultivation
period 
Following
operation
Result
1 M/44 SJS, chronic  Intractable PED 8 mm-  Total Mother 2 weeks None Successful. Maintain clear
dacryocystitis for 5 m. diameter round F/70 surface for 5 weeks
2 M/48 Alkali burn,  Severe fibrosis, 4 mm- Total Contralateral  2 weeks  CLAU Successful. Maintain clear
symblepharon thinning diameter round eye surface for 4 weeks
3 M/37 Alkali burn Intractable PED  6 x 4 mm  Total Brother  3 weeks  Cadeveric  Successful. 
for 5 m. M/34 KLAL, Decreased size of PED.
PKP Maintain clear surface for 27
weeks, followed by PKP
Table 1. Clinical data for four eyes that underwent in vivo cultivated corneal epithelium transplantation
Clinical success was defined by the epithelium of cornea recovery and maintenance of an intact epithelial surface for 4 weeks. According to this def-
inition of clinical success, the clinical success rate of these cases were 100% and this procedure seems to be very effective. In cases 1 and 2, the
ocular surface recovered for 4 weeks. However, the epithelial defect recurred because of chronic inflammation and chronic exposure, respectively.
In case 3, the cornea recovered after surgery, was maintained for 27 weeks and followed by PKP.
SJS, Steven-Johnson syndrome; PED, persistent epithelial defect; CLAU, conjunctivolimbal autograft; KLAL, keratolimbal allograft; PKP, penetrating
keratoplasty.504 J.T. Kim, Y.S. Chun, G.Y. Song, et al.
age of more than 5 points at 40,000 magnification. In addi-
tion, immunohistochemical staining was performed in case
1. The monoclonal antibodies against p63 and Integrin β 4
were purchased from Santa Cruz (Santa cruz Biotechnology,
Santa Cruz, CA, U.S.A.), and the polyclonal antibody against
Connexin 43 was purchased from Chemicon (Millipore Cor-
poration, Billerica, MA, U.S.A.). Immunohistochemical stain-
ing was performed to evaluate the expression of different
molecular markers that have been proposed to identify epithe-
lial basal cells and differentiated cells. In brief, the expanded
corneal epithelium were fixed in 2% paraformaldehyde in
PBS at 4℃ for 10 min and then permealized with 0.2%
TritonX-100 in PBS at room temperature for 10 min. the
endogenous peroxidase were quenched with 0.3% H2O2 in
0.5% horse serum in PBS and incubated with 5% horse
serum to block the non-specific sites. Monoclonal antibod-
ies against p63 (1:1,000), integrin β 4 (1:200), or polyclonal
antisera against Connexin 43 (1:200) was applied and incu-
bated for 1 hr at room temperature, followed by incubation
with biotinyated second antibodies, anti-mouse or anti-rab-
bit IgG, using a Vectastain Elite ABC Kit, according to the
manfacturer’s protocol. The samples were finally incubated
with DAB peroxidase substrate to give a brown stain and
counterstained with hematoxylin. After washing with PBS,
the samples were mounted and analysed. 
Evaluation of clinical findings
Epithelial integrity, recurrence of erosion, and decreased
size of the PED on the patient’s cornea were evaluated post-
operatively (1st day, 3rd day, and every week) using slit lamp
examination. In addition, the presence of corneal erosion,
opacity, and neovascularization on the donor’s cornea were
evaluated. A clinical success was defined as intact epitheli-
um that was maintained for longer than 4 weeks.
RESULT
Microscopic findings
The cultivated epithelial sheet on the donor cornea was
Fig. 1. Slit lamp findings of donor cornea and structural findings of in vivo expanded corneal epithelium on donor cornea at 2 weeks of
cultivation (case 1). (A) Denuded AM was transplanted onto the cornea using a continuous suture with #10-0 Nylon after epithelial peel-
ing. Epithelialization on the AM was complete by 2 weeks after the AM transplantation. (B) HE staining demonstrated well differentiated
multilayer epithelium in the in vivo expanded epithelial sheet under the light microscopy (×200). (C) EM showed a well developed hemidesmo-
some (arrows).
A
B
C 1 μ m
Fig. 2. Immunohistochemical staining of p63 (A), Connexin 43 (B)
and Integrin β 4 (C) from the corneal epithelial culture of the donor’s
cornea at 2 weeks of cultivation (case 1) (×400).
(A) p63 was expressed by the epithelial basal cells. (B) Connexin
43 was expressed in the intercellular space. (C) Integrin β 4 was
expressed in the intercellular space, predominantly the basal cell
layer.
A
B
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well differentiated and multilayered in appearance; they look-
ed normal under the light microscope. They showed marked-
ly stratified epithelia with cuboidal basal epithelial cells and
a scanty cytoplasm. The epithelialization on the AM of the
donor cornea was completed 2 weeks after expansion. After
that time, they showed a well-formed hemidesmosome under
the electron microscope (Fig. 1B, C). The calculated hemides-
mosome density was 4.3±1.2/2.25 μ m, 4.0±1.6/2.25 μ m,
and 4.2±0.6/2.25 μ m at 2, 3, and 7 weeks of culture, respec-
tively. 
On immunohistochemical staining of case 1, p63, con-
nexin 43, and integrin β 4, were expressed in the epithelial
sheet representing well-developed adhesion complexes, inter-
cellular junctions, and the existence of epithelial cells (Fig. 2).
Clinical findings
The epithelium that was expanded on the donor cornea
was transparent and clear just like normal corneal epitheli-
um. Clinically, the PED of the recipient’s cornea was healed
with these epithelial sheets (Fig. 3, 4). However, a ban-
dage contact lens was needed to protect the cornea because
of its fragility. In detail, the surface of cornea was covered
with in vivo expanded epithelium, but a slight small sized-
A B
C D
Fig. 3. A 44-yr-old patient with Steven Johnson syndrome (case 1) had PED (8 mm diameter), present for more than 5 months (A, C). How-
ever, the epithelial defect was completely covered with the in vivo expanded epithelial sheet 2 weeks after surgery (B, D). 506 J.T. Kim, Y.S. Chun, G.Y. Song, et al.
erosion was present. The in vivo grown corneal epithelium
functioned successfully in all cases; the clinical success rate
was 100%. The PED in all cases was covered by 2 weeks
after surgery (average 2 weeks). The transplanted epitheli-
um was maintained for 5, 4, and 27 weeks on each of the
patient’s cornea, respectively (average 12 weeks). The PED
recurred in cases 1 and 2 (SJS and severe alkali burn patients).
A clear surface was maintained for 27 weeks in case 3, and
was followed by a penetrating keratoplasty procedure. The
donor cornea recovered completely without any complica-
tions at 1 week, 10 days after harvest. Complications such
as recurrent erosion, corneal opacity, and neovasculization
were not observed.
DISCUSSION
The aim of this study was to evaluate the treatment of
PED with total limbal deficiency using in vivo cultivated
epithelium. The reconstruction of a severly injured cornea is
a challenging problem in ophthalmology. Thus, many exper-
imental methods have been attempted to recover and stabi-
lize the ocular surface prior to performing a penetrating ker-
atoplasty. To date, the limbal autograft or allograft has been
A B
C D
Fig. 4. A 37-yr-old patient with alkali burns (case 3) had PED, presented for more than 5 months (A, C). The epithelial defect was completely
covered, but erosion in another area developed 2 weeks after surgery (B, D). In Vivo Grown Corneal Epithelium Transplantation on Intractable PED 507
most commonly used. However, a variety of obstacles has
prevented the clinical success of theses procedures. A limbal
autograft requires a large amount of limbal tissue from the
healthy eye and is not an option for diseases or injuries that
are bilateral. An allograft always carries the risk for rejection
and requires patient immunosuppressive treatment for life.
As both corneal stem cells and antigen presenting cells (APCs)
are transplanted together in limbal allografts, they show
intense and frequent rejection. However, very few or almost
no APCs are contained in cultivated corneal epithelial sheets
ex vivo or in vivo (11). 
The most recently used, ‘ex vivo’ cultivated corneal epithe-
lial transplatation is a very new surgical treatment for severe
stem cell deficiency. This new approach has often proven
very successful in maintaining good vision in SJS and chemi-
cal burn patients (6, 7, 12-14). However, application of this
procedure is limited by the facilities and equipment needed.
Therefore, in vivo expansion may be preferred to ex vivo expan-
sion. 
Previously, we established a well-differentiated multilay-
ered corneal epithelium with adequate hemidesmosome den-
sity after 3 months of culture (9). However, this procedure
was limited to cell culture of the damanged cornea. There-
fore, in this study we investigated corneal epithelium, expand-
ed in vivo in the healthy cornea of living relatives or from the
contralateral eye of patients with PED.
Reports have indicated that the prognosis of penetrating
keratoplasty (PKP) and limbal transplantation is better in
cases where major histocompatibility complex antigens are
matched (15, 16). In addition, the antigen-associated blood
type is present in corneal epithelial cells (17, 18). Thus, to
reduce immune rejection, the cornea from a living relative
that is matched for blood type was used for the donor of
epithelium in all cases. Epithelialization of in vivo expan-
sion was completed and an adhesion complex like hemides-
mosome was present after 2 weeks of expansion, a shorter
time than with a damaged cornea.
In vivo expansion on a healthy cornea and donation of the
epithelial sheets was a more invasive procedure than a lim-
bal graft. However, the intractable PED did not heal after
the limbal graft. The cornea of the donor was completely
epithelialized at 7-10 days after the harvest. Complications
such as recurrent erosion, corneal opacity, and neovasculiza-
tion were not observed.
In the three cases with PED, the hemidesmosome density
was calculated. They were 4.3±1.2/2.25 μ m, 4.0±1.6/2.25
μ m, and 4.2±0.6/2.25 μ m. They were greater than or equal
to the normal value (3.7±60.11/2.25 μ m) (19). In addition,
immunohistochemical staining results indicated that the
epithelial cells were well differentiated and the adhesion com-
plex of epithelial sheets was well developed. These findings
showed that corneal epithelia, using in vivo expansion, were
well developed after 2 weeks of cultivation. However, inte-
grin β 4 was not stained well in the basement membrane,
although a well differentiated hemidesmosome was noted.
Further studies are needed to better understand the devel-
opment and differentiation of the hemidesmosome in the in
vivo expanded epithelial sheets.
In the case with SJS, the covered epithelial sheet was melt-
ed at the fifth week; the epithelial defect along with neovas-
cularization recurred soon after. The cause of this complica-
tion might be chronic inflammation, dry eye syndrome, or
the toxicity of the eyedrops for chronic dacryocystitis. The
patient received two additional expanded epithelium trans-
plantations, ex vivo and in vivo. However, the ocular surface
has not improved, and the PED and neovascularization
recurred.
In case 2, the patient had severe symblepharon of the eye,
and adhesiolysis and AM transplantation on the bulbar and
tarsal conjunctiva could not be carried out under ideal con-
ditions. A slightly incomplete eye closure remained, which
would contribute to the recurrence of corneal erosion. These
finding demonstrate the importance of micro-environmen-
tal factors on the ocular surface.
AM is now widely used as an ideal biosubstrate for base-
ment membrane, not only as a surgical material for ocular
surface reconstruction, but also an as acellular substrate for
tissue engineering (20, 21). In addition, the basement mem-
brane of AM is reported to resemble that of the conjunctival
epithelium and closely resembles the basement membrane
of corneal epithelium (22). Therefore, preserved AM is con-
sidered an appropriate carrier material for the transplanta-
tion of cultivated corneal epithelial cells. Moreover, denud-
ed AM has been reported to be more useful than intact AM
for the promotion of prompt migration of corneal epithelial
cells in vitro and expansion of corneal epithelium (11, 23,
24). Therefore, we used denuded AM as substrate for the
basement membrane.
In conclusion, we have described three patients with an
epithelial defect of the cornea that was not responsive to stan-
dard medical and surgical treatment. We, therefore, intro-
duced a new procedure for transplantation of corneal epithe-
lium, grown in vivo. The PED responded to the in vivo epithe-
lial sheet transplantation. This is the first report on the recon-
struction of severely damaged cornea using an epithelial sheet
expanded in vivo onto the healthy cornea of a living relative.
The results suggest that this approach may be another effec-
tive therapeutic option for treatment of PED in severely dam-
aged ocular surface disease. 
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